Parkinson disease is the second most common neurodegenerative disorder. Its annual cost in Europe in 2010 was around 14,000 million Euros, and its effect on the quality of life of patients and their families is incalculable (The Lancet 383; 1107-1109, 2014).



Subscribe to our newsletter:

We don’t spam! Read our privacy policy for more info.